Accurate Investment Solutions’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-810
Closed -$80K 475
2019
Q3
$80K Hold
810
0.06% 100
2019
Q2
$75K Sell
810
-75
-8% -$7.12K 0.06% 96
2019
Q1
$83K Buy
885
+75
+9% +$6.56K 0.07% 87
2018
Q4
$52K Hold
810
0.05% 111
2018
Q3
$72K Hold
810
0.05% 108
2018
Q2
$64K Sell
810
-5
-0.6% -$415 0.05% 128
2018
Q1
$73K Hold
815
0.06% 117
2017
Q4
$85K Hold
815
0.06% 101
2017
Q3
$119K Buy
815
+10
+1% +$1.36K 0.09% 87
2017
Q2
$105K Hold
805
0.09% 82
2017
Q1
$100K Hold
805
0.08% 72
2016
Q4
$93K Buy
805
+5
+0.6% +$557 0.08% 81
2016
Q3
$84K Hold
800
0.08% 84
2016
Q2
$79K Hold
800
0.08% 81
2016
Q1
$80K Hold
800
0.08% 114
2015
Q4
$96K Buy
+800
New +$92.6K 0.09% 76

Other funds holding CELG

Accurate Investment Solutions's CELG Position: Q4 2019 in Review

Accurate Investment Solutions sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 810 shares — an estimated $80K sold.

Accurate Investment Solutions first reported a position in CELG in Q4 2015 and held it in 16 quarters. The position peaked at $119K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Accurate Investment Solutions reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Accurate Investment Solutions sold 810 Celgene Corp shares in Q4 2019, an estimated $80K.
  • Accurate Investment Solutions first reported a position in Celgene Corp in Q4 2015 and held it in 16 quarters.
  • Accurate Investment Solutions's Celgene Corp position peaked at $119K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Accurate Investment Solutions's 13F filing for Q4 2019, filed 8 Jan 2020.